Yield10 Bioscience Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
YTEN Nasdaq 8731 http://www.yield10bio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Yield10 Bioscience Inc

Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference - May 19th, 2022 12:30 pm
Metabolix, Inc. (YTEN) Reports Q1 Loss, Misses Revenue Estimates - May 11th, 2022 9:15 pm
Yield10 Bioscience Announces First Quarter 2022 Financial Results - May 11th, 2022 8:02 pm
Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, 2022 - May 3rd, 2022 12:30 pm
Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill Executive, as Special Commercial and Technical Advisor - Apr 27th, 2022 1:15 pm
Should You Buy Wheat Stocks? 3 Companies To Consider. - Apr 8th, 2022 11:25 pm
10 GMO Stocks to Invest in Now - Mar 28th, 2022 2:23 pm
Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat - Mar 22nd, 2022 12:30 pm
Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference - Mar 16th, 2022 12:30 pm
Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results - Mar 9th, 2022 9:02 pm
Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic - Mar 8th, 2022 1:30 pm
Yield10 Bioscience Announces an Update on the Camelina Line E3902 Development Program for Producing Low-carbon Feedstock Oil for Renewable Diesel - Mar 3rd, 2022 1:30 pm
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wednesday, March 9, 2022 - Mar 2nd, 2022 1:30 pm
Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola - Mar 1st, 2022 1:30 pm
Yield10 Bioscience Receives Favorable Ruling from the Argentine Biosafety Commission (CONABIA) for Company’s Camelina Lines - Feb 2nd, 2022 1:30 pm
Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations - Jan 25th, 2022 1:30 pm
Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference - Jan 4th, 2022 1:30 pm
Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021 - Dec 6th, 2021 1:30 pm
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference - Dec 2nd, 2021 1:30 pm
Will Yield10 Bioscience (NASDAQ:YTEN) Spend Its Cash Wisely? - Nov 22nd, 2021 5:28 pm